Clinical trials
Low Back Pain trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 8 |
| 2022 | 13 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Recruiting | 14 |
| Unknown status | 10 |
| Terminated | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 14 |
| Centre Hospitalier Universitaire de Nīmes | 11 |
| University Hospital, Montpellier | 7 |
| Centre Hospitalier Universitaire de Nice | 3 |
| CHU de Reims | 2 |
| Centre Hospitalier Universitaire de Saint Etienne | 2 |
| Fondation Hôpital Saint-Joseph | 2 |
| Grünenthal GmbH | 2 |
| LNA SANTE | 2 |
| Thuasne | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Low Back Pain | 85 |
| Chronic Pain | 6 |
| Pain | 6 |
| Intervertebral Disc Degeneration | 3 |
| Kinesiophobia | 3 |
| Back Pain | 2 |
| Musculoskeletal Diseases | 2 |
| Sciatica | 2 |
| Anxiety Disorders | 1 |
| Arachnodactyly | 1 |
Trials
Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.